[
  {
    "uuid": "9fbd1a08cb3345393cd295a9edf79f5fde42acc3",
    "url": "https://www.mql5.com/en/forum/479343",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Tman Bab",
    "published": "2025-01-09T15:13:00Z",
    "title": "MT4 TERMINAL FROZEN",
    "text": "MT4 TERMINAL FROZEN\nHello, please assist. my mt4 terminal does not respond, it does not show charts but only displays\" WAITING FOR UPDATES\". IT does not respond to commands. it is frozen. When the network is off the terminal knobs respond but with no chart display and no symbol data.\n2025.01.09 00:18:26.218 Data Folder: C:\\Users\\TLAMELO\\AppData\\Roaming\\MetaQuotes\\Terminal\\2191F4A3D14D7B4B1EBB84F924777883 2025.01.09 00:18:26.218 Windows 10 Home Single Language x64, UAC, 2 x Intel Celeron N3060 @ 1.60GHz, Memory: 927 / 4001 Mb, Disk: 97 / 450 Gb, GMT+2 2025.01.09 00:18:26.218 Exness Technologies MT4 build 1431 started (Exness Technologies Ltd)\n#1\nYour topic has been moved to the section:\nPlease consider which section is most appropriate —\nMQL4 and MetaTrader 4Please consider which section is most appropriate —\nhttps://www.mql5.com/en/forum/172166/page6#comment_49114893#2\nTman Bab: Hello, please assist. my mt4 terminal does not respond, it does not show charts but only displays\" WAITING FOR UPDATES\". IT does not respond to commands. it is frozen. When the network is off the terminal knobs respond but with no chart display and no symbol data.\n- First make sure that the network connection is working correctly, by checking the icon in the bottom-right, to make sure the trade server is properly connected and that the data is flowing.\n- Also check the Journal log to make sure there are no connection problems or other error messages.\n- If all the above is working, then close all your charts, and then open them again by right-clicking the respective symbols in the Market Watch window and choosing the \"Chart Window\" option.\nIf this does not resolve the issue, show us the complete Journal log entries.\n#3\nFernando Carreiro\nYour topic has been moved to the section:\nPlease consider which section is most appropriate —\nMy apologies .Thank You .\n#:Your topic has been moved to the section:\nMQL4 and MetaTrader 4Please consider which section is most appropriate —\nhttps://www.mql5.com/en/forum/172166/page6#comment_49114893#4\nFernando Carreiro\nhttps://www.mql5.com/en/forum/479343#comment_55581718:- First make sure that the network connection is working correctly, by checking the icon in the bottom-right, to make sure the trade server is properly connected and that the data is flowing.\n- Also check the Journal log to make sure there are no connection problems or other error messages.\n- If all the above is working, then close all your charts, and then open them again by right-clicking the respective symbols in the Market Watch window and choosing the \"Chart Window\" option.\nIf this does not resolve the issue, show us the complete Journal log entries.\nThank you for the reply .\nall the above mentioned is checked.\nplease note however that all other terminals from other brokers work perfectly.\n- When wifi is on the terminal just remain frozen you can't click anything on it.\n- when wifi is off that's when i can interact with it.\n- All these is with no charts displayed and no data on market watch.\nYou are missing trading opportunities:\n- Free trading apps\n- Over 8,000 signals for copying\n- Economic news for exploring financial markets\nRegistration\nLog in\nYou agree to website policy and terms of use\nIf you do not have an account, please",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Science and Technology",
      "Economy, Business and Finance",
      "Human Interest"
    ],
    "topics": [
      "Science and Technology->technology and engineering",
      "Economy, Business and Finance->computing and information technology"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2025-01-10T10:25:44.976+02:00",
    "updated": "2025-01-10T10:25:44.976+02:00"
  },
  {
    "uuid": "57d592eab6ed5eabfa47650cee7225cde4c2085e",
    "url": "https://www.folhavitoria.com.br/geral/noticia/03/2024/chuva-na-regiao-serrana-do-rj-pode-ter-mesmo-volume-que-causou-tragedia-em-2011-alerta-cemaden",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Folha Vitória",
    "published": "2024-03-22T18:43:00Z",
    "title": "Chuva na região serrana do RJ pode ter mesmo volume que causou tragédia em 2011, alerta Cemaden",
    "text": "Chuva na região serrana do RJ pode ter mesmo volume que causou tragédia em 2011, alerta Cemaden As previsões foram divulgadas pelo Centro Nacional de Monitoramento e Alertas de Desastres Naturais (Cemaden) O Rio de Janeiro deve enfrentar neste fim de semana chuvas intensas com acumulados superiores a 200 milímetros por dia, um patamar semelhante ao que desencadeou a tragédia vista no Estado em 2011, quando cerca de mil pessoas morreram em deslizamentos na região serrana. As previsões foram divulgadas pelo Centro Nacional de Monitoramento e Alertas de Desastres Naturais (Cemaden), que espera grandes volumes de chuva a partir da tarde desta sexta-feira, 22. >> Quer receber nossas notícias 100% gratuitas? Participe da nossa [comunidade no WhatsApp ](https://chat.whatsapp.com/CUtNx3TkdVqG4crbyEEpGg)ou entre no nosso [canal do Telegram!](https://t.me/folhavitoriaoficial) A maior intensidade é prevista para a madrugada de sexta-feira para sábado, 23, dia apontado como mais crítico, especialmente, na região serrana do Estado. \"Episódios de deslizamentos podem ser generalizados. Não podemos descartar, inclusive, episódios mais graves, levando em conta o volume previsto, com corridas de massa ou corrida de detritos\", afirmou o coordenador de operações do Cemaden, Marcelo Seluchi, em coletiva de imprensa. Na região metropolitana e no sul do Estado, o volume de chuva deve seguir a mesma média prevista para a região serrana. Ainda que os maiores riscos estejam concentrados na serra, o norte do Estado e a costa oeste também devem registrar chuvas fortes. LEIA TAMBÉM: [Alerta vermelho para chuvas: cidades do ES orientam moradores sobre riscos](https://www.folhavitoria.com.br/geral/noticia/03/2024/previsao-tempo-hoje-es-alerta-chuva-forte-onde-vai-chover) As previsões levaram o governador do estado, Cláudio Castro (PL) a decretar ponto facultativo no Rio de Janeiro. \"Peço que as pessoas fiquem em casa e não se arrisquem em locais ao ar livre\", disse em comunicado nas redes sociais. O monitoramento de risco do Cemanden está sendo atualizado e divulgado em tempo real nas redes do governo do Estado durante o fim de semana. O Cemaden foi fundado em 2011, quando acumulados de chuva eram semelhantes ao previsto para esse fim de semana. Na ocasião, chuvas fortes atingiram 16 cidades do Rio de Janeiro; Teresópolis, Nova Friburgo e Petrópolis foram as mais afetadas. Ao todo, o número de mortos se aproximou de mil, enquanto cerca de 25 mil ficaram desabrigados. LEIA TAMBÉM: [Rio terá ponto facultativo nesta sexta-feira e mobilização contra chuvas fortes](https://www.folhavitoria.com.br/geral/noticia/03/2024/ponto-facultativo-no-rio-hoje-chuvas-e-previsao-do-tempo-no-fim-de-semana) \"O que haveria de semelhança em relação a 2011: acumulados de chuvas superiores a 200 milímetros, possivelmente de 300 milímetros. Números também observados em janeiro de 2011?, disse Giovanni Dolif, meteorologista e pesquisador do Cemaden ao canal CNN. Regina Alvalá, coordenadora do Cemaden, explica que as previsões para desastres são baseadas em uma somatória de fatores que possibilitam a avaliação de riscos. \"Olhamos, além das previsões de tempo, para as chuvas que já caíram e o solo absorveu em dias pretéritos, mais a chuva que esteja caindo no momento e mais a previsão do tempo\", afirmou. A chuva, segundo o Instituto Nacional de Meteorologia (Inmet) é consequência da aproximação de uma frente fria que avançou pela Região Sul do País na quinta-feira. \"Ao longo da sexta (22) e do sábado (23), a previsão é de que esse sistema atue pelo leste da Região Sudeste causando grandes volumes, podendo levar transtornos à população\", informou o órgão federal em nota. LEIA TAMBÉM: [Motociclista morre e moto fica destruída em acidente no Norte do ES](https://www.folhavitoria.com.br/geral/noticia/03/2024/motociclista-morre-e-moto-fica-destruida-em-acidente-no-norte-do-es)",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "portuguese",
    "sentiment": "negative",
    "categories": [
      "Weather"
    ],
    "external_links": [
      "https://chat.whatsapp.com/CUtNx3TkdVqG4crbyEEpGg)ou",
      "https://t.me/folhavitoriaoficial)",
      "https://www.chat.whatsapp.com/CUtNx3TkdVqG4crbyEEpGg)ou",
      "https://www.t.me/folhavitoriaoficial)"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-03-22T22:11:44.510+02:00",
    "updated": "2024-03-22T22:11:44.510+02:00"
  },
  {
    "uuid": "afd78cfec446408481ccd753a3c1bc99ae96661d",
    "url": "https://www.rtp.pt/noticias/eleicoes-europeias-2024/macron-alerta-para-ameaca-de-ingovernabilidade-se-extrema-direita-aumentar_n1577525",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Rádio e Televisão de Portugal",
    "published": "2024-06-06T22:22:00Z",
    "title": "Macron alerta para ameaça de ingovernabilidade se extrema-direita aumentar",
    "text": "Macron alerta para ameaça de ingovernabilidade se extrema-direita aumentar O Presidente francês, Emmanuel Macron, alertou hoje que se as eleições europeias de 09 de junho resultarem num grande grupo de extrema-direita no Parlamento Europeu, a União Europeia \"poderá ficar bloqueada\". \"Uma Europa onde a extrema-direita é forte, se houver uma nova pandemia, a Europa não nos vai proteger (...) se amanhã a extrema-direita tiver uma minoria capaz de bloquear [o Parlamento], não vamos ter uma Europa das vacinas, essas pessoas vão dar-vos cloroquina e a vacina [russa] Sputnik\", disse o Presidente francês. Em entrevista ao canal France 2 e TF1, Emmanuel Macron apelou a uma afluência massiva às urnas no dia 09 de junho, por considerar que haverá uma luta contra a abstenção, recordando o que aconteceu no referendo do Brexit de 2016, quando \"os britânicos não foram votar e outros acabaram por votar por eles\". Este aviso surge numa altura em que o partido de extrema-direita francês União Nacional (RN) de Marine Le Pen, liderado por Jordan Bardella, tem uma grande vantagem nas últimas sondagens, cerca de 33% das intenções de voto, o dobro do partido presidencial (16%), de Valérie Hayer e do Partido Socialista-Place Publique, de Raphaël Glucksmann (14,5%).",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "portuguese",
    "sentiment": "negative",
    "categories": [
      "Politics",
      "Social Issue"
    ],
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-06-07T02:03:00.125+03:00",
    "updated": "2024-06-07T02:03:00.125+03:00"
  },
  {
    "uuid": "8524ca716c9426c174fd97cabd16f175e42eac2e",
    "url": "https://lancasteronline.com/sports/tennis/frances-tiafoe-taylor-fritz-brace-for-historic-all-american-semifinal-match-with-trip-to-us/article_3aa24a89-fd58-5e44-99e0-d2b88ab52885.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Peter Sblendorio - New York Daily News (TNS)",
    "published": "2024-09-05T21:37:00Z",
    "title": "Frances Tiafoe, Taylor Fritz brace for historic all-American semifinal match with trip to US Open final on the line | Pro Tennis",
    "text": "September 5, 2024 79° Frances Tiafoe, Taylor Fritz brace for historic all-American semifinal match with trip to US Open final on the line Peter Sblendorio - New York Daily News (TNS) Sep 5, 2024 6 mins ago Facebook Twitter WhatsApp SMS Email Facebook Twitter WhatsApp SMS Email Print Copy article link NEW YORK — For the first time since 2006, an American will appear in the men’s singles final at the US Open.\nWhich American that is remains to be seen.\nTaylor Fritz and Frances Tiafoe, the polar-opposite U.S. stars whose simultaneous Open runs have captivated Queens, are set to battle Friday night in a much-anticipated semifinal match at Arthur Ashe Stadium.\nIt’s the first time since 2005 that two American men will face each other in an Open semifinal, helping to restore a level of local intrigue that’s long been missing from the country’s top tennis tournament.\n“Let the best man win,” Tiafoe said Tuesday after beating Bulgaria’s Grigor Dimitrov in the quarterfinal. “It’s going to be epic. Popcorn. Do what you got to do. It’s going to be a fun one.”\nTiafoe and Fritz, both 26, are fighting for a spot in the Open final, where whomever advances will play the winner of Friday’s other semifinal match between Italy’s Jannik Sinner and the U.K.’s Jack Draper.\nFritz and Tiafoe are eminently familiar with each other, dating back more than a decade to when they competed in 14-and-under tournaments. Both turned pro in 2016 and have faced each other seven times since, with Fritz going 6-1 in those meetings and winning the last six.\nFritz’s head-to-head wins include beating his countryman in the second round of the 2022 Australian Open, as well as in the Acapulco quarterfinal last year.\nThey’ve never met at the US Open. Until now.\n“It’s different on Ashe, man,” Tiafoe said. “It’s different. Obviously, you have to learn from those [past meetings]. A couple of those I thought I actually should have won. He’s tough, man. He’s a tough player. He plays great from both sides, has a great serve. He’s moving much better now. It’s going to be tough. It’s going to be a big moment for both of us.”\nFriday’s winner will become the first American man to advance to the Open final since Andy Roddick in 2006, as well as the first American man to reach a Grand Slam final since Roddick at Wimbledon in 2009.\nRoddick remains the last American man to win the Open, having done so in 2003.\nThe last all-American semifinal match at the Open saw Andre Agassi advance past Robby Ginepri in five sets, then lose in the final to Roger Federer. That was the second of five consecutive titles for Federer at the Open, a tournament that Novak Djokovic and Rafael Nadal also won four times apiece over the last 15 years.\n“Taylor and I had a conversation about being 1, 2 Americans for a very long time,” Tiafoe said. “I remember we were sitting on a plane some years ago, and he’s a pretty to-himself kind of dude, and he’s, like, bro, I think me and you are going to be 1, 2 Americans and leading the way.\n“Coming from him, I was, like, dang, dude, 6 a.m., I’m pretty tired, but let’s do it. Why not? He’s had that mindset and he’s pushed me a lot.”\nFritz (No. 12) and Tiafoe (No. 20) are two of five Americans in the ATP’s top-20 rankings.\nTiafoe already won a high-profile all-U.S. match at this Open, defeating 13th-seeded Ben Shelton in a five-set, four-hour marathon in the third round last Friday. He needed only four sets to eliminate the ninth-seeded Dimitrov.\nFritz, meanwhile, topped the world’s No. 4 player, Germany’s Alexander Zverev, in the quarterfinal to set up Friday’s match with Tiafoe.\n“That’s going to be a lot of fun,” Fritz said of facing Tiafoe. “That’s going to be just electric.”\nIt’s Fritz’s first time advancing to a Grand Slam semifinal after coming up short in his first four trips to a major quarterfinal. Two of those losses were to Djokovic, including at last year’s Open, and another was to Nadal.\n“It’s cool I’m in the semis, but I very much have the mindset [that] the job’s not done,” Fritz said Tuesday after defeating Zverev in four sets.\n“A question I got asked pretty much every time I lost in the quarterfinals was, ‘What’s it going to take to go further?’ The answer I gave was always just keep putting myself in these situations, and I’ll become more comfortable in these situations and get better. That’s definitely what happened now.”\nThis is Tiafoe’s second trip to the Open semifinal, having lost in five sets to eventual champion Carlos Alcaraz in 2022. Tiafoe, too, is seeking his first Grand Slam title.\nThe Maryland-born Tiafoe remains a fan favorite at Flushing Meadows, where Mikal Bridges, Kevin Hart and Tony Goldwyn are among the stars who have attended his matches.\nFritz, who hails from Southern California, has drawn large crowds and loud cheers throughout the two-week tournament as well.\n“He’s a video-game, never-leave-the-room goofball,” Tiafoe said of Fritz. “I’m loud and obnoxious at times. But he’s also very funny. He’s got that dry humor, smart ass, but at the same time, that’s why we like each other, because we’re so different. That’s why we get along so well.\n“And then as competitors, we are very [alike],” Tiafoe said. “[We] hate to lose.”\n©2024 New York Daily News. Visit nydailynews.com . Distributed by Tribune Content Agency, LLC.\nNewsletter Success! An email has been sent to with a link to confirm list signup.\nError! There was an error processing your request.\nSports Our daily sports newsletter, delivered at 6 a.m. Please enter a valid email address. Sign up By opting into newsletters you are agreeing to our privacy policy . What to Read Next <img src=\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAB JCAQAAACRI2S5AAAAEklEQVR42mP8X8+AFzCOKgADAJ1vDXivFXd/ ElFTkSuQmCC\" srcset=\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAB JCAQAAACRI2S5AAAAEklEQVR42mP8X8+AFzCOKgADAJ1vDXivFXd/ ElFTkSuQmCC\" sizes=\"(min-width: 1200px) 171px, (min-width: 768px) calc(15.00vw - 30px), 100vw\" width height alt=\"{{title}}\" class=\"img-responsive full white\" loading=\"lazy\"}\"> {{hammer}} {{kicker}} {{title}} {{subhead}} {{byline}} Dec 31, 1969 Copyright 2024 Tribune Content Agency.\nFacebook Twitter WhatsApp SMS Email Print Copy article link",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Sport",
      "Human Interest",
      "Arts, Culture and Entertainment"
    ],
    "ai_allow": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": null,
    "rating": null,
    "crawled": "2024-09-06T00:45:14.989+03:00",
    "updated": "2024-09-06T01:30:02.199+03:00"
  },
  {
    "uuid": "0eb08b779a4454accb90bb0c1ec45ea2024bfcdb",
    "url": "https://www.wlrn.org/health/2024-04-11/how-personalized-drug-treatments-can-lead-to-better-faster-outcomes-in-cancer-patients",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Diana Azzam | Florida International University",
    "published": "2024-04-11T21:30:00Z",
    "title": "How personalized drug treatments can lead to better, faster outcomes in cancer patients | WLRN",
    "text": "How personalized drug treatments can lead to better, faster outcomes in cancer patients The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts. Cancer patients are also getting younger. Cancer diagnoses among those under 50 has risen by [about 80% worldwide](https://doi.org/10.1136/bmjonc-2023-000049) over the past 30 years. As of 2023, cancer is the [second-leading cause of death](https://doi.org/10.3322/caac.21834) both in the U.S. and around the world. While death rates from cancer have decreased over the past few decades, [about 1 in 3 patients in the U.S.](https://doi.org/10.3322/caac.21763) and [1 in 2 patients worldwide](https://doi.org/10.3322/caac.21834) still die from cancer. Despite advances in standard cancer treatments, many cancer patients still face uncertain outcomes when these treatments prove ineffective. Depending on the stage and location of the cancer and the patient’s medical history, most cancer types are treated with a mix of radiation, surgery and drugs. But if those standard treatments fail, patients and doctors enter a trial-and-error maze where effective treatments become difficult to predict because of limited information on the patient’s cancer. My mission as a [cancer researcher](https://scholar.google.com/citations?hl=en&user=v42J5dMAAAAJ) is to build a personalized guide of the most effective drugs for every cancer patient. My team and I do this by testing different medications on a patient’s own cancer cells before administering treatment, tailoring therapies that are most likely to selectively kill tumors while minimizing toxic effects. In our newly published results of the first clinical trial combining drug sensitivity testing with DNA testing to identify effective treatments in children with cancer, an approach called [functional precision medicine](https://doi.org/10.1038/nm.4389), we found this approach [can help match patients](https://www.nature.com/articles/s41591-024-02848-4) with more FDA-approved treatment options and significantly improve outcomes. What is functional precision medicine? Even though two people with the same cancer might get the same medicine, they can have very different outcomes. Because [each patient’s tumor is unique](https://theconversation.com/every-cancer-is-unique-why-different-cancers-require-different-treatments-and-how-evolution-drives-drug-resistance-199249), it can be challenging to know which treatment works best. To solve this problem, doctors analyze DNA mutations in the patient’s tumor, [blood](https://theconversation.com/a-blood-test-that-screens-for-multiple-cancers-at-once-promises-to-boost-early-detection-191728) or saliva to match cancer medicines to patients. This approach is called [precision medicine](https://doi.org/10.1038/nm.4389). However, the relationship between cancer DNA and how effective medicines will be against them is very complex. Matching medications to patients based on a single mutation overlooks other genetic and nongenetic mechanisms that influence how cells respond to drugs. How to best match medicines to patients through DNA is still a major challenge. Overall, [only 10% of cancer patients](https://www.nature.com/articles/s41591-024-02848-4) [experience a clinical benefit](https://doi.org/10.1016/j.annonc.2021.04.003) from treatments matched to tumor DNA mutations. Functional precision medicine takes a different approach to personalizing treatments. My team and I take a sample of a patient’s cancer cells from a biopsy, grow the cells in the lab and expose them to over 100 drugs approved by the Food and Drug Administration. In this process, called [drug sensitivity testing](https://doi.org/10.1200/po.20.00438), we look for the medications that kill the cancer cells. New clinical trial results Providing functional precision medicine to cancer patients [in real life](https://www.nature.com/articles/s41591-024-02848-4) is very challenging. [Off-label use of drugs](https://theconversation.com/off-label-use-is-common-in-medicine-a-bioethicist-and-legal-philosopher-explain-why-the-covid-19-vaccines-are-different-171007) and financial restrictions are key barriers. The health of cancer patients can also deteriorate rapidly, and physicians may be hesitant to try new methods. But this is starting to change. Two teams in Europe recently showed that functional precision medicine could match effective treatments to [about 55% of](https://doi.org/10.1158/2159-8290.cd-21-0538) [adult patients](https://doi.org/10.1158/2159-8290.cd-21-0410) with blood cancers such as leukemia and lymphoma that did not respond to standard treatments. Most recently, my team’s clinical trial [focused on childhood cancer patients](https://www.nature.com/articles/s41591-024-02848-4) whose cancer came back or didn’t respond to treatment. We applied our functional precision medicine approach to 25 patients with different types of cancer. Our trial showed that we could provide treatment options for almost all patients in less than two weeks. My colleague [Arlet Maria Acanda de la Rocha](https://scholar.google.com/citations?hl=es&user=XZGLaW4Rm9IC) was instrumental in helping return drug sensitivity data to patients as fast as possible. We were able to provide test results within 10 days of receiving a sample, compared with the roughly 30 days that standard genomic testing results that focus on identifying specific cancer mutations typically take to process. Most importantly, our study showed that [83% of cancer patients](https://www.nature.com/articles/s41591-024-02848-4) who received treatments guided by our approach had clinical benefit, including improved response and survival. Expanding into the real world Functional precision medicine opens new paths to understanding how cancer drugs can be better matched to patients. Although doctors can read any patient’s DNA today, interpreting the results to understand how a patient will respond to cancer treatment is much more challenging. Combining drug sensitivity testing with DNA analysis can help personalize cancer treatments for each patient. I, along with colleague [Noah E. Berlow](https://scholar.google.com/citations?user=qHhkvO J&hl=en), have started to add artificial intelligence to our functional precision medicine program. AI enables us to analyze each patient’s data to better match them with tailored treatments and drug combinations. AI also allows us to understand the complex relationships between DNA mutations within tumors and how different treatments will affect them. My team and I have [started two](https://classic.clinicaltrials.gov/ct2/show/NCT05857969) [clinical trials](https://classic.clinicaltrials.gov/ct2/show/NCT06024603) to expand the results of our previous studies on providing treatment recommendations through functional precision medicine. We’re recruiting a larger cohort of adults and children with cancers that have come back or are resistant to treatment. The more data we have, the easier it will become to understand how to best treat cancer and ultimately help more patients access personalized cancer treatments. This article is republished from The Conversation under a Creative Commons license. Read the original article [here](https://theconversation.com/personalized-cancer-treatments-based-on-testing-drugs-quickly-leads-to-faster-treatment-better-outcomes-221469.).",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "external_links": [
      "https://doi.org/10.1016/j.annonc.2021.04.003)",
      "https://doi.org/10.3322/caac.21763)",
      "https://doi.org/10.1158/2159-8290.cd-21-0538)",
      "https://doi.org/10.1158/2159-8290.cd-21-0410)",
      "https://scholar.google.com/citations?hl=en&user=v42J5dMAAAAJ)",
      "https://doi.org/10.1038/nm.4389).",
      "https://classic.clinicaltrials.gov/ct2/show/NCT06024603)",
      "https://theconversation.com/a-blood-test-that-screens-for-multiple-cancers-at-once-promises-to-boost-early-detection-191728)",
      "https://scholar.google.com/citations?hl=es&user=XZGLaW4Rm9IC)",
      "https://doi.org/10.1136/bmjonc-2023-000049)",
      "https://doi.org/10.1200/po.20.00438),",
      "https://theconversation.com/every-cancer-is-unique-why-different-cancers-require-different-treatments-and-how-evolution-drives-drug-resistance-199249),",
      "https://theconversation.com/off-label-use-is-common-in-medicine-a-bioethicist-and-legal-philosopher-explain-why-the-covid-19-vaccines-are-different-171007)",
      "https://doi.org/10.1038/nm.4389),",
      "https://www.nature.com/articles/s41591-024-02848-4)",
      "https://classic.clinicaltrials.gov/ct2/show/NCT05857969)",
      "https://theconversation.com/personalized-cancer-treatments-based-on-testing-drugs-quickly-leads-to-faster-treatment-better-outcomes-221469.).",
      "https://doi.org/10.3322/caac.21834)",
      "https://scholar.google.com/citations?user=qHhkvOAAAAAJ&hl=en),",
      "https://nature.com/articles/s41591-024-02848-4)",
      "https://www.theconversation.com/personalized-cancer-treatments-based-on-testing-drugs-quickly-leads-to-faster-treatment-better-outcomes-221469.).",
      "https://www.doi.org/10.1136/bmjonc-2023-000049)",
      "https://www.scholar.google.com/citations?hl=es&user=XZGLaW4Rm9IC)",
      "https://www.doi.org/10.1158/2159-8290.cd-21-0538)",
      "https://www.classic.clinicaltrials.gov/ct2/show/NCT05857969)",
      "https://www.theconversation.com/every-cancer-is-unique-why-different-cancers-require-different-treatments-and-how-evolution-drives-drug-resistance-199249),",
      "https://www.doi.org/10.1200/po.20.00438),",
      "https://www.doi.org/10.3322/caac.21834)",
      "https://www.classic.clinicaltrials.gov/ct2/show/NCT06024603)",
      "https://www.doi.org/10.1038/nm.4389).",
      "https://www.theconversation.com/off-label-use-is-common-in-medicine-a-bioethicist-and-legal-philosopher-explain-why-the-covid-19-vaccines-are-different-171007)",
      "https://www.doi.org/10.3322/caac.21763)",
      "https://scholar.google.com/citations",
      "https://www.doi.org/10.1158/2159-8290.cd-21-0410)",
      "https://www.doi.org/10.1016/j.annonc.2021.04.003)",
      "https://www.doi.org/10.1038/nm.4389),",
      "https://www.scholar.google.com/citations?user=qHhkvOAAAAAJ&hl=en),",
      "https://www.scholar.google.com/citations?hl=en&user=v42J5dMAAAAJ)",
      "https://www.theconversation.com/a-blood-test-that-screens-for-multiple-cancers-at-once-promises-to-boost-early-detection-191728)"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": [
        {
          "name": "u.s.",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-04-12T02:06:43.136+03:00",
    "updated": "2024-04-12T02:06:43.136+03:00"
  },
  {
    "uuid": "a82a6bd35e4d3b5e07f7692d097b82a9c3c43373",
    "url": "https://eldiariony.com/2024/05/10/gran-tormenta-solar-azotara-a-la-tierra-este-fin-de-semana-repercusiones-en-estados-unidos",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Montserrat Arqué",
    "published": "2024-05-10T16:44:00Z",
    "title": "Gran tormenta solar azotará a la Tierra este fin de semana: Repercusiones en Estados Unidos",
    "text": "Gran tormenta solar azotará a la Tierra este fin de semana: Repercusiones en Estados Unidos\nDesde hace 25 años no se registraba un fenómeno solar de tal magnitud\nEl Servicio Meteorológico Nacional de Estados Unidos ha emitido una alerta de tormenta geomagnética grave, anunciando una situación excepcional como resultado de una serie de erupciones solares. Esta advertencia, la primera en 2 décadas, se presenta como una medida de precaución ante posibles impactos en la infraestructura orbital terrestre y en la superficie de la Tierra.\nSegún el comunicado emitido por el Centro de Predicción del Clima Espacial (SWPC, por sus siglas en inglés) de la Oficina Nacional de Administración Oceánica y Atmosférica (NOAA, por sus siglas en inglés), las erupciones solares que han desencadenado esta alerta comenzaron el pasado 8 de mayo, y las condiciones para la persistencia de la tormenta podrían extenderse a lo largo del fin de semana.\nUna gran mancha solar ha sido identificada como el origen de estas erupciones, las cuales han variado en intensidad desde moderadas hasta muy fuertes en los últimos días.\n“Una gran mancha solar ha producido erupciones desde moderadas a muy fuertes desde el miércoles. Al menos cinco de esas erupciones estuvieron asociadas con eyecciones de masa de la corona solar que parecen dirigidas hacia la Tierra”, señaló la agencia en su comunicado.\nEstas eyecciones de masa coronal son explosiones de plasma y campos magnéticos en la corona solar que pueden generar tormentas geomagnéticas cuando se dirigen hacia nuestro planeta, explicó NOAA. La intensidad de estas erupciones solares es similar, según la plataforma Spacewather, a un huracán de categoría 4.\nQué provocará esta tormenta solar en Estados Unidos\nSegún la NOAA, esta tormenta solar podría desencadenar una serie de efectos adversos, que pueden ir desde irregularidades en el sistema eléctrico hasta interrupciones en la comunicación y la navegación por satélite.\nLa intermitencia en la navegación por satélite (GPS) es otra consecuencia potencial, lo que podría afectar la precisión de los sistemas de posicionamiento utilizados en una amplia gama de aplicaciones, desde la navegación marítima hasta la aviación comercial.\nAsimismo, las comunicaciones por radio de alta frecuencia (HF) pueden experimentar interrupciones intermitentes debido a las perturbaciones geomagnéticas, lo que podría afectar las operaciones de comunicación críticas, especialmente en áreas remotas o en situaciones de emergencia.\nAdemás de estos efectos tecnológicos, la NOAA indicó que podrían observarse auroras boreales en distintos puntos de EE.UU., extendiéndose a regiones del sur como Iowa, Oregon, hasta Alabama y California.\nPara aquellos que deseen presenciar estas magníficas auroras, se recomienda buscar áreas con poca contaminación lumínica y cielos despejados durante la noche. Además, seguir las actualizaciones proporcionadas por la NOAA y otras fuentes confiables puede ayudar a determinar el mejor momento y lugar para observarlas.\nSigue leyendo:\n*",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Weather"
    ],
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-05-10T19:57:32.025+03:00",
    "updated": "2024-05-10T19:57:32.025+03:00"
  }
]